Overview
Gilgamesh Pharmaceuticals is a clinical stage biotechnology company [1] founded in 2020. The company participated in Y Combinator's Summer 2020 batch [3] and maintains operations in New York City, NY, USA, as well as remote locations [2]. As of the time of listing, the company had a team size of 15 [4]. Gilgamesh focuses on mental health science and develops innovative new chemical entities through a combination of medicinal chemistry, intellectual property strategy, neuroscience and neurobiology, and drug development expertise [5]. The company's team brings experience in biotech exits and inventions [5].
Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions. [5]
Y Combinator's directory lists the company location as New York City, NY, USA; New York, NY, USA; Remote. [2]
Growth & traction
Y Combinator lists a team size of 15. [4]
Something wrong or missing? Send an update. Fixed within 24 hours.